85111-802-16 : NDC 2026 Code

85111-802-16 : Dextromethorphan, Guaifenesin ( Curewell Tussin Dm )

Additionally :

You can get information about “85111-802-16” NDC code in 85111-802-16 in HTML format

HTML | 85111-802-16 in TXT (Plain Text) format

TXT | 85111-802-16 in PDF (Portable Document Format)

PDF | 85111-802-16 in XML format

XML formats.

NDC Code : 85111-802-16 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "85111-802-16",
    "PackageDescription": "473 mL in 1 BOTTLE (85111-802-16) ",
    "NDC11Code": "85111-0802-16",
    "ProductNDC": "85111-802",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Curewell Tussin Dm",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dextromethorphan, Guaifenesin",
    "DosageFormName": "LIQUID",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260401",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "RMT HEALTH LLC",
    "SubstanceName": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
    "StrengthNumber": "20; 200",
    "StrengthUnit": "mg/10mL; mg/10mL",
    "Pharm_Classes": "Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-04-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260401",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}